NO20040653L - Nytt glykolipid og medisin for autoimmunsykdom inneholdende det samme som aktiv ingrediens. - Google Patents

Nytt glykolipid og medisin for autoimmunsykdom inneholdende det samme som aktiv ingrediens.

Info

Publication number
NO20040653L
NO20040653L NO20040653A NO20040653A NO20040653L NO 20040653 L NO20040653 L NO 20040653L NO 20040653 A NO20040653 A NO 20040653A NO 20040653 A NO20040653 A NO 20040653A NO 20040653 L NO20040653 L NO 20040653L
Authority
NO
Norway
Prior art keywords
new
active ingredient
same
autoimmune disease
gen
Prior art date
Application number
NO20040653A
Other languages
English (en)
Other versions
NO326398B1 (no
Inventor
Takashi Yamamura
Sachiko Miyake
Original Assignee
Japan Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Government filed Critical Japan Government
Publication of NO20040653L publication Critical patent/NO20040653L/no
Publication of NO326398B1 publication Critical patent/NO326398B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20040653A 2001-08-16 2004-02-13 Nytt glykolipid og medisin for autoimmunsykdom inneholdende det samme som aktiv ingrediens. NO326398B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001247055 2001-08-16
PCT/JP2002/008280 WO2003016326A1 (fr) 2001-08-16 2002-08-14 Glycolipide et agent therapeutique pour maladies auto-immunes le contenant en tant qu'ingredient actif

Publications (2)

Publication Number Publication Date
NO20040653L true NO20040653L (no) 2004-05-07
NO326398B1 NO326398B1 (no) 2008-11-24

Family

ID=19076468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040653A NO326398B1 (no) 2001-08-16 2004-02-13 Nytt glykolipid og medisin for autoimmunsykdom inneholdende det samme som aktiv ingrediens.

Country Status (15)

Country Link
US (1) US8367623B2 (no)
EP (1) EP1437358B1 (no)
JP (1) JP4064346B2 (no)
KR (1) KR100880063B1 (no)
CN (1) CN100439383C (no)
AT (1) ATE342910T1 (no)
AU (1) AU2002327097B2 (no)
BR (1) BR0211968A (no)
CA (1) CA2459482C (no)
DE (1) DE60215530T2 (no)
DK (1) DK1437358T3 (no)
ES (1) ES2274080T3 (no)
HU (1) HU229345B1 (no)
NO (1) NO326398B1 (no)
WO (1) WO2003016326A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
KR20050105215A (ko) * 2003-02-14 2005-11-03 다이이치 아스비오파마 가부시키가이샤 당지질 유도체 및 그 제조 방법 및 그 합성 중간체 및 그제조 방법
AU2005280163B2 (en) * 2004-08-27 2011-11-24 Albert Einstein College Of Medicine, Inc. Ceramide derivatives as modulators of immunity and autoimmunity
US8513008B2 (en) 2004-10-07 2013-08-20 Argos Therapeutics, Inc. Mature dendritic cell compositions and methods for culturing same
CN101080487B (zh) 2004-10-07 2012-11-14 阿戈斯治疗公司 成熟树突细胞组合物及其培养方法
US7923013B2 (en) 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
JP5090928B2 (ja) * 2004-12-28 2012-12-05 ザ ロックフェラー ユニバーシティ Ｎｋｔ細胞に対する抗原としての糖脂質及びその類似体
JP4909264B2 (ja) * 2005-04-01 2012-04-04 独立行政法人理化学研究所 経鼻ワクチン
RU2008103792A (ru) * 2005-07-01 2009-08-10 Джапэн Эз Репризентид Бай Президент Оф Нэшнл Сентер Оф Ньюролоджи Энд Сайкайатри (Jp) Производное гликолипидов и лекарственное средство, содержащее это производное в качестве активного компонента
WO2007049819A1 (ja) * 2005-10-28 2007-05-03 Japan As Represented By President Of National Center Of Neurology And Psychiatry Nkt細胞の機能を抑制する糖脂質誘導体を有効成分とする治療剤
WO2007099999A1 (ja) * 2006-02-28 2007-09-07 Riken 新規糖脂質及びその用途
WO2008005824A1 (en) 2006-06-30 2008-01-10 The Scripps Research Institute Adjuvants and methods of use
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
CA2678618C (en) 2007-02-21 2019-03-12 Vaccinex, Inc. Modulation of nkt cell activity with antigen-loaded cd1d molecules
ES2574825T3 (es) * 2007-10-12 2016-06-22 Luigi Panza Análogos de glicolípidos útiles como inmunoadyuvantes
AU2010203451B2 (en) * 2009-01-08 2016-06-30 Albert Einstein College Of Medicine, Inc. Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
JP6202339B2 (ja) * 2013-12-19 2017-09-27 国立研究開発法人国立精神・神経医療研究センター ＧＭ−ＣＳＦ産生Ｔ細胞制御剤、及びＴｈ１／Ｔｈ２免疫バランス調節剤
EP3111945B1 (en) 2014-02-26 2021-07-14 National University Corporation Hokkaido University Dendritic cells for use in the treatment of myocardial infarction
CN114096260A (zh) 2019-07-12 2022-02-25 国立大学法人九州大学 心肌收缩改善治疗法和心肌细胞死亡抑制法的开发
AU2022228420A1 (en) 2021-03-01 2023-10-05 Deciduous Therapeutics, Inc. Compounds for activating invariant natural killer t-cells and methods of use in eliminating inflammatory senescent cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5827828A (ja) * 1981-08-11 1983-02-18 Mitsubishi Electric Corp 燃料噴射装置
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
JPH0559081A (ja) * 1991-08-29 1993-03-09 Kirin Brewery Co Ltd 新規スフインゴ糖脂質、その製造法および使用
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
GB9207182D0 (en) * 1992-04-01 1992-05-13 Enzymatix Ltd Glycolipids and their preparation
TW261533B (no) * 1992-07-16 1995-11-01 Kirin Brewery
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
KR950032254A (ko) * 1994-05-31 1995-12-20 야마다니 와다루 당지질 동족체
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
JP4451933B2 (ja) * 1996-12-27 2010-04-14 住友化学株式会社 遺伝子操作による植物へのｐｐｏ阻害性除草剤耐性付与法
KR100527950B1 (ko) * 1997-04-10 2005-11-09 기린 비루 가부시키가이샤 알파-글리코실세라미드를 함유하는 엔케이티 세포활성화제
US6589940B1 (en) * 1997-06-06 2003-07-08 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
US7273711B1 (en) * 1998-12-02 2007-09-25 The Regents Of The University Of California Diagnosis of human glycosylation disorders
JP2002284692A (ja) * 2001-03-26 2002-10-03 Kirin Brewery Co Ltd α−グリコシルセラミドによる移植片対宿主病（ＧＶＨＤ）の抑制

Also Published As

Publication number Publication date
CN1568328A (zh) 2005-01-19
HU229345B1 (en) 2013-11-28
KR20040039287A (ko) 2004-05-10
JP4064346B2 (ja) 2008-03-19
CA2459482A1 (en) 2003-02-27
CN100439383C (zh) 2008-12-03
JPWO2003016326A1 (ja) 2004-12-02
DE60215530T2 (de) 2007-05-31
WO2003016326A1 (fr) 2003-02-27
ATE342910T1 (de) 2006-11-15
DK1437358T3 (da) 2007-02-05
BR0211968A (pt) 2004-09-28
AU2002327097B2 (en) 2007-05-24
CA2459482C (en) 2010-09-28
NO326398B1 (no) 2008-11-24
DE60215530D1 (de) 2006-11-30
EP1437358A1 (en) 2004-07-14
EP1437358A4 (en) 2004-11-24
HUP0500127A2 (en) 2006-09-28
US20060148723A1 (en) 2006-07-06
US8367623B2 (en) 2013-02-05
ES2274080T3 (es) 2007-05-16
KR100880063B1 (ko) 2009-01-22
EP1437358B1 (en) 2006-10-18
HUP0500127A3 (en) 2009-12-28

Similar Documents

Publication Publication Date Title
NO20040653L (no) Nytt glykolipid og medisin for autoimmunsykdom inneholdende det samme som aktiv ingrediens.
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
PL1609785T3 (pl) Pochodne c-glikozydowe i ich sole
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
EP1553094A4 (en) AZULATE DERIVATIVES AND THEIR SALTS
AR030816A1 (es) Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos
MY123244A (en) N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-iv
IL151757A0 (en) Glucopyranosyloxy benzylbenzene derivatives, medicinal compounds containing the same and intermediates for the preparation of the derivatives
MXPA04004548A (es) Acidos heteroarilalalcanoicos substituidos y su uso como inhibidores de aldosa reductasa.
NZ284654A (en) Oxazolyl substituted 3,5-dioxo-oxadiazolidine or 2,4-dioxo-thiazolidine derivatives and medicaments
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SG86284A1 (en) Use of (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide for the manufacture of medicaments for the treatment of anxiety
WO2002092072A3 (en) Drugs for the treatment of the alzheimer disease
EA200100916A1 (ru) Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
NO20030639D0 (no) Piperidinderivater og legemidler inneholdende disse derivater som den aktive bestanddel
AU7916394A (en) Dithiocarbonimide derivative, fungicidal/insecticidal/ acaricidal agent containing said derivative as active ingredient, intermediate for use in production of said derivative and process for producing said derivative from said intermediate
NO20056135L (no) Karboksylforbindelse og medisin som omfatter denne
NO20043286L (no) Piperidinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
TW280810B (no)
ZA949973B (en) Eburnane analogues a process for the preparation thereof and pharmaceutical compositions containing them
DE60211686D1 (de) Pkb-3564-substanz mit die gefässneubildung hemmender wirkung
CA2083609A1 (en) Preventive or therapeutic agent for ischemia-reperfusion tissue injury, arrhythmia and lung injury caused by active oxygens and free radicals
PT1235850E (pt) 14,15-ciclopropano-androstanos insaturados, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos
ATE392883T1 (de) Ein sesquiterpen-lacton enthaltende zusammensetzung

Legal Events

Date Code Title Description
MK1K Patent expired